Wellington Shields & Co’s Stereotaxis STXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.9K Hold
40,079
0.02% 300
2026
Q1
$73.7K Sell
40,079
-2,448
-6% -$5.37K 0.02% 287
2025
Q4
$97.8K Sell
42,527
-466
-1% -$1.24K 0.02% 283
2025
Q3
$134K Hold
42,993
0.03% 261
2025
Q2
$91.1K Sell
42,993
-1,800
-4% -$3.66K 0.03% 268
2025
Q1
$78.8K Hold
44,793
0.02% 262
2024
Q4
$102K Buy
44,793
+3,600
+9% +$7.53K 0.03% 246
2024
Q3
$84K Buy
41,193
+4,000
+11% +$8.05K 0.03% 269
2024
Q2
$67.7K Hold
37,193
0.02% 268
2024
Q1
$97.1K Hold
37,193
0.03% 250
2023
Q4
$65.1K Buy
37,193
+1,800
+5% +$2.91K 0.02% 257
2023
Q3
$55.9K Hold
35,393
0.01% 257
2023
Q2
$54.2K Sell
35,393
-2,000
-5% -$3.71K 0.01% 260
2023
Q1
$76.3K Hold
37,393
0.02% 259
2022
Q4
$77.4K Buy
37,393
+21,893
+141% +$42.8K 0.02% 255
2022
Q3
$28K Hold
15,500
0.01% 265
2022
Q2
$29K Hold
15,500
0.01% 268
2022
Q1
$58K Buy
+15,500
New +$73.2K 0.02% 220

Other funds holding STXS

Wellington Shields & Co's STXS Position: Q2 2026 in Review

Wellington Shields & Co held its Stereotaxis (STXS) position steady in Q2 2026 at 40,079 shares worth $68.9K. The position accounts for 0.02% of the portfolio, ranked #300.

Wellington Shields & Co first reported a position in STXS in Q1 2022 and has held it in 18 quarters since. The position peaked at $134K in Q3 2025. 109 funds tracked by Wall St. Rank hold STXS as of Q2 2026.

  • Wellington Shields & Co held 40,079 shares of Stereotaxis worth $68.9K as of Q2 2026.
  • Wellington Shields & Co left its Stereotaxis share count unchanged in Q2 2026.
  • Stereotaxis made up 0.02% of Wellington Shields & Co's portfolio in Q2 2026, its #300 holding.
  • Wellington Shields & Co first reported a position in Stereotaxis in Q1 2022 and has held it in 18 quarters since.
  • Wellington Shields & Co's Stereotaxis position peaked at $134K in Q3 2025.
  • 109 funds tracked by Wall St. Rank held Stereotaxis as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.